Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Co-infusion of UCB and Haploidentical CD34+ Cells in SAA and MDS
NCT00604201Phase 2Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- May 2008
- Primary completion
- Oct 2016
- Modality
- Hematopoietic Stem Cells
- Countries
- 1
01
Overview
A Phase 2 trial of umbilical cord blood in aplastic anemia, myelodysplastic syndrome (MDS), sponsored by National Heart, Lung, and Blood Institute. Started May 2008; status: completed.
02
Drugs
umbilical cord blood
03
Conditions
aplastic anemiamyelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT00604201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00604201.